Tag: EmBlok

EMBLOK Announces Enrollment of 50th Patient in Clinical Trial for Emblok™ Embolic Protection System for use in TAVR Procedures, Appoints Scientific and Strategic Advisory Board

Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity TAMPA, Fla., Oct. 8, 2024 /PRNewswire/ — EMBLOK™ (emblok.com), a privately held medical device company developing the most…

Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of its Next Generation EMBLOK™ Embolic Protection System

MILAN, March 2, 2021 /PRNewswire/ — Innovative Cardiovascular Solutions (ICS), a privately held medical device company developing the most complete comprehensive solution to embolic protection for structural heart and vascular interventions, announced today the success of its first European clinical cases using the […]

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

KALAMAZOO, Mich., July 11, 2017 /PRNewswire/ — Innovative Cardiovascular Solutions, LLC (ICS), a privately-held clinical stage company headquartered in Kalamazoo, MI, announced today completion of an oversubscribed Series B round of financing totaling $5M USD. The company is currently developing the EMBLOK™ Embolic Protection System […]

Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of EMBLOK Embolic Protection System

NEWS PROVIDED BY Innovative Cardiovascular Solutions 15 Mar, 2017, 15:09 ET SHARE THIS ARTICLE MILAN, March 15, 2017 /PRNewswire/ — Innovative Cardiovascular Solutions (ICS), a privately held medical device company pioneering novel solutions for embolic protection during transcatheter aortic valve replacement […]